Supernus Pharmaceuticals ... (SUPN)
NASDAQ: SUPN
· Real-Time Price · USD
46.56
-0.54 (-1.15%)
At close: Sep 25, 2025, 10:15 AM
Supernus Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Hold
Price Target
43
Upside
-7.65
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Piper Sandler | Hold | Maintains | 36 40 | -14.09% | Aug 29, 2025 | |
| Cantor Fitzgerald | Buy | Maintains | 42 46 | -1.20% | Aug 6, 2025 | |
| Cantor Fitzgerald | Hold | Reiterates | 36 36 | -22.68% | Feb 26, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.